Discover perspectives on the latest findings, biggest challenges and most exciting successes in our collective work.
At P-Values, you’ll find updates, perspective, insights and information from staff and partners working on the frontlines of research, advocacy and implementation. P-value is a statistical term for the probability that a trial result is reliable and not the outcome of chance.
Blog Post
AVAC calls for the immediate rejection of the Global Gag Rule and any expansion of it and urges US lawmakers to uphold science, human rights, and public health.
Blog Post
This week marks 365 days of disruption and chaos across global health, with many organizations and journalists reflecting on one year after the foreign aid freeze and what the future of global health looks like. We are also watching closely for news of an expanded Global Gag Rule.
Blog Post
This week marks one year since the US Presidential Administration issued a deeply cruel executive order freezing foreign assistance. To mark this moment, AVAC’s One Year Later series reflects on the impact of the past 365 days on five key areas of global health and development
showing 1-10 of 1176
AVAC calls for the immediate rejection of the Global Gag Rule and any expansion of it and urges US lawmakers to uphold science, human rights, and public health.
This week marks 365 days of disruption and chaos across global health, with many organizations and journalists reflecting on one year after the foreign aid freeze and what the future of global health looks like. We are also watching closely for news of an expanded Global Gag Rule.
Prevention Option:
This week marks one year since the US Presidential Administration issued a deeply cruel executive order freezing foreign assistance. To mark this moment, AVAC’s One Year Later series reflects on the impact of the past 365 days on five key areas of global health and development
Prevention Option:
As we wrap up our ‘One Year Later’ series, in this fifth installment, we look to the future and what is built next. Champions of global health must define the architecture of the future, or it will be written by people bent on dismantling it.
In the fourth installment of our ‘One Year Later’ series we focus on lenacapavir and how science is breaking through formidable barriers in understanding HIV and how to prevent it, just as the infrastructure for delivering groundbreaking technology is defunded and destabilized.
This third installment of our ‘One Year Later’ series examines this administration’s sustained assault on the research enterprise. What has unfolded is a 365-day cascade of policy, programmatic and, financial actions that threaten US leadership and the scientific ecosystem responsible for lifesaving breakthroughs.
The second piece in AVAC’s ‘One Year Later’ series is out. From cuts to HIV vaccine research to attacks on ACIP and Gavi, we break down how ideology is undermining evidence and why global health depends on defending science.
AVAC’s ‘One Year Later’ series reflects on the tumultuous events of the past 365 days across five global health issues. First up: how the foreign aid freeze and abuse of executive power are costing lives.
The US foreign assistance budget, if enacted, would restore some global health funds in a broader context of uncertainty, as US bilateral “America First” health MoUs advance without transparent plans for implementation or accountability. At the same time, abrupt reversals by the US Department of Health and Human Services of troubling health policy decisions underscore the Administration’s instability. Meanwhile, momentum around lenacapavir continues, recently approved by Brazil and with additional funding from Unitaid to reach more populations in South Africa and Zambia.
On January 20, join us and Jeanne Marrazzo, IDSA CEO and AVAC board member, for The Future of HIV Prevention: A People’s Research Agenda for Speed, Scale and Equity, a webinar exploring the PRA’s people-centered framework, what the PRA tracks, why it matters and what’s at stake.
showing 1-10 of 1176
Discover perspectives on the latest findings, biggest challenges and most exciting successes in our collective work.
AVAC’s email list for organization and individuals interested in timely updates and critical perspectives on developments in biomedical HIV prevention.
A comprehensive round-up of HIV prevention media coverage and scientific publications.
Each month this podcast uses interviews, discussion and first-person reflections to explore vital topics confronting the field of HIV prevention research.
PxWire is AVAC’s quarterly update on biomedical HIV prevention. Each issue highlights key developments, challenges and opportunities, and features a centerspread infographic that provides a visual tool for framing these issues.
Pandemic Watch is a curated news digest on the latest pandemic prevention, preparedness, and response (PPPR) news and resources.
A collection of official statements from AVAC.
Media clippings featuring AVAC, its staff and close partners in the news media.